Doctor profile · Federal record
Dr. Rachel Stadelmann, CNP
Nurse Practitioner · Boston, MA
- NPI 1841716503
- Accepts Medicare
- 9 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
800 Washington St
Boston, MA 021111552
(617) 636-5000
Credentials & registration
- NPI registered
- August 2017 — 9 yrs on file
- Profile last updated
- February 3, 2025
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Massachusetts #RN2301095
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1841716503. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,031
Distinct HCPCS
5
Medicare allowed
$79,664
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 647 | 178 | $70 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 161 | 138 | $115 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 147 | 56 | $88 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 64 | 34 | $31 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 12 | 11 | $89 |
In context: peer comparison
Among 151 peers in Boston Nurse Practitioner, average services per provider: 101. This provider delivers 10× the peer median.Open Payments
Industry payments received
All-time total
$427
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Roche Diabetes Care, INC. | 1 | $318.00 | |
| Lilly USA, LLC | 1 | $108.90 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
765
Patients
173
Total drug cost
$487,016
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trulicity (Dulaglutide) | Brand | 157 | 34 | $194,336 |
| Metformin Hcl | Generic | 65 | 17 | $724 |
| Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) | Brand | 62 | 16 | $34,082 |
| Jardiance (Empagliflozin) | Brand | 59 | 16 | $71,974 |
| Ozempic (Semaglutide) | Brand | 56 | 13 | $59,319 |
| Nano 2Nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 55 | 19 | $5,454 |
| Rybelsus (Semaglutide) | Brand | 50 | 11 | $55,724 |
| Glipizide | Generic | 44 | 11 | $343 |
| Omnipod 5 G6 Pods (Gen 5) (Insulin Pump Cart,Automated,Bt) | Brand | 42 | 0 | $30,875 |
| Unifine Pentips (Pen Needle, Diabetic) | Brand | 34 | 12 | $1,456 |
Hospital affiliations
Frequently asked questions
What is Dr. Rachel Stadelmann's medical specialty?
Dr. Rachel Stadelmann practices Nurse Practitioner in Boston, MA.
Where does Dr. Rachel Stadelmann practice?
Dr. Rachel Stadelmann practices at 800 Washington St, Boston, MA 021111552. Office phone: 6176365000.
What is Dr. Rachel Stadelmann's NPI?
Dr. Rachel Stadelmann's National Provider Identifier (NPI) is 1841716503, issued by NPPES.
Does Dr. Rachel Stadelmann accept Medicare assignment?
Yes. Dr. Rachel Stadelmann accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rachel Stadelmann commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Initial hospital care with straightforward or low-level medical decision making (HCPCS 99222); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.